查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1702782

2025年全球製氧機市場報告

Artificial Lung Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年人工肺市場將快速成長。到 2029 年，這一數字將成長至 40.6 億美元，複合年成長率為 11.9%。預測期內的成長是由於呼吸系統疾病盛行率上升、醫療設施改善、微創手術接受度提高、患者生活品質改善、慢性阻塞性肺病盛行率上升。預測期內的關鍵趨勢包括無線技術的融合、人工智慧 (AI) 的融合、基因組學和醫療技術的進步以及更小、更便攜的人工肺的開發。

由於呼吸系統疾病的日益流行，人工肺市場預計將會成長。受空氣污染加劇、氣候變遷和生活方式改變等因素的影響，這種成長給公眾健康帶來了巨大負擔。人工肺透過提供氧氣、去除血液中的二氧化碳以及支持或替代受損的肺功能，在呼吸系統疾病的治療中發揮著至關重要的作用。例如，根據澳洲健康與福利研究所2024年6月的報告，估計澳洲約有850萬人，即34%的人口患有慢性呼吸道疾病。其中，280 萬人（佔總人口的 11%）患有氣喘，638,000 人（佔總人口的 2.5%）患有慢性阻塞性肺病(COPD)。因此，呼吸系統疾病盛行率的不斷上升是人工肺部市場擴張的關鍵驅動力。

為了獲得競爭優勢，氧合器市場的主要企業正專注於開拓創新解決方案，例如遠端監控和控制系統。這些系統允許醫療專業人員遠端監測患者的生命徵象並調整呼吸設置，而無需站在床邊。這種方法有助於降低感染風險並提高治療期間患者的安全性。例如，2022年8月，美國電子製造商Teltonika Telemedic在其人工肺人工呼吸器TELTOMED的研發中取得重大突破。該公司已獲得人工呼吸器安全遠端傳輸和控制的獨家專利，提高了現代醫療設備至關重要的患者資料通訊的安全性和可靠性。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球人工肺PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球製氧機市場：成長率分析
  • 全球製氧機市場表現：規模與成長，2019-2024
  • 全球製氧機市場預測：規模與成長，2024-2029 年，2034 年
  • 氧合器的全球總目標市場（TAM）

第6章市場區隔

  • 全球製氧機市場：按產品類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 單滾輪泵心肺機
  • 雙滾輪泵心肺機
  • 氣泡氧合器
  • 膜式氧合器
  • 全球人工肺市場：按應用、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 心血管手術
  • 肺移植手術
  • 急性呼吸衰竭的治療
  • 其他用途
  • 全球製氧機市場：按最終用戶、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 急診中心
  • 其他最終用戶
  • 全球氧合器市場單滾輪泵型心肺氧合器細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 可攜式單滾輪泵心肺機
  • 固定式單滾輪泵式體外循環機
  • 全球氧合器市場雙滾泵心肺氧合器細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 可攜式雙滾泵體外循環機
  • 固定式雙滾輪幫浦式體外循環機
  • 全球製氧機市場氣泡製氧機細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 一次使用氣泡氧合器
  • 可重複使用的氣泡氧合器
  • 全球氧合器市場膜氧合器細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 氧合膜氧合器
  • 二氧化碳脫除膜氧合器

第7章 區域和國家分析

  • 全球製氧機市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球製氧機市場：依國家/地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 人工肺市場：競爭格局
  • 氧合器市場：公司簡介
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Getinge AB Overview, Products and Services, Strategy and Financial Analysis
    • Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • MicroPort Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
    • Charles Stark Draper Laboratory Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • TransMedics Group Inc.
  • Braile Biomedica Ltd.
  • Xenios AG
  • MC3 Cardiopulmonary Inc.
  • Lung Biotechnology PBC
  • Breethe Inc.
  • Levitronix LLC
  • Medos Medizintechnik AG
  • ALung Technologies Inc.
  • McGowan Institute for Regenerative Medicine
  • Hemovent GmbH
  • Novalung GmbH
  • Haemair Ltd.
  • MedArray Inc.
  • Vivonics Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年氧合器市場：提供新機會的國家
  • 2029 年氧合器市場：細分市場帶來新機會
  • 2029年制氧機市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r29436

An artificial lung is a medical device created to assume the function of natural lungs by supplying oxygen to the blood and eliminating carbon dioxide. It is commonly employed in patients experiencing severe respiratory failure or during surgeries where temporary cessation of heart and lung function is necessary. This technology aims to support or replace lung function, facilitating patient survival and recovery from critical conditions.

The primary types of artificial lungs include single roller pump heart-lung machines, double roller pump heart-lung machines, bubble artificial lungs, and membrane artificial lungs. A single roller pump heart-lung machine operates using a single roller pump to circulate blood through an artificial lung and back into the patient during cardiopulmonary bypass surgery. These machines are utilized in cardiac surgery, lung transplants, acute respiratory failure treatments, and other medical procedures, catering to diverse end users such as hospitals, emergency centers, and healthcare facilities.

The artificial lung research report is one of a series of new reports from The Business Research Company that provides artificial lung market statistics, including the artificial lung industry's global market size, regional shares, competitors with an artificial lung market share, detailed artificial lung market segments, market trends and opportunities, and any further data you may need to thrive in the artificial lung industry. This artificial lung market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial lung market size has grown rapidly in recent years. It will grow from $2.31 billion in 2024 to $2.59 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to growing awareness among healthcare professionals, increasing market penetration, increasing applications in-home care setting, the rise in medical tourism, and improvements in healthcare infrastructure.

The artificial lung market size is expected to see rapid growth in the next few years. It will grow to $4.06 billion in 2029 at a compound annual growth rate (CAGR) of 11.9%. The growth in the forecast period can be attributed to the rising prevalence of respiratory diseases, improvements in healthcare facilities, rising acceptance of minimally invasive procedures, enhanced patient quality of life, and rising prevalence of chronic obstructive pulmonary diseases. Major trends in the forecast period include the integration of wireless technology, artificial intelligence (AI) integration, advances in genomics and medical technology, and the development of smaller, more portable artificial lungs.

The artificial lung market is expected to experience growth driven by the increasing prevalence of respiratory diseases. This rise is influenced by factors such as escalating air pollution, climate changes, and shifts in lifestyle, placing a substantial burden on public health. Artificial lungs play a critical role in treating respiratory conditions by providing oxygenation and removing carbon dioxide from the blood, supporting or replacing impaired lung function. For example, as reported by the Australian Institute of Health and Welfare in June 2024, approximately 8.5 million people in Australia, constituting 34% of the population, were estimated to have chronic respiratory conditions. This includes 2.8 million people (11% of the population) with asthma and 638,000 people (2.5% of the population) with chronic obstructive pulmonary disease (COPD). Thus, the growing prevalence of respiratory diseases is a key driver behind the expansion of the artificial lung market.

Major companies in the artificial lung market are focusing on developing innovative solutions, such as remote monitoring and control systems, to gain a competitive edge. These systems enable healthcare professionals to monitor patients' vital signs and adjust ventilation settings remotely, without needing to be physically present at the bedside. This approach helps reduce the risk of infection and improves patient safety during treatment. For example, in August 2022, Teltonika Telemedic, a U.S.-based electronics manufacturer, made significant strides in developing its artificial lung ventilator, TELTOMED. The company secured an exclusive patent for the secure remote transmission and control of its ventilator, enhancing the security and reliability of patient data communication-an essential feature for modern medical devices.

In May 2022, LivaNova plc, a UK-based medical device company, acquired ALung Technologies to bolster its portfolio in advanced respiratory therapies. This acquisition aimed to strengthen LivaNova's capability to deliver innovative solutions for respiratory support, particularly focusing on advancing artificial lung technologies. ALung Technologies, headquartered in the US, specializes in developing intra- and extracorporeal gas exchange devices for treating acute and chronic respiratory disorders.

Major companies operating in the artificial lung market are Terumo Corporation, Getinge AB, Abiomed Inc., MicroPort Scientific Corp., Charles Stark Draper Laboratory Inc., TransMedics Group Inc., Braile Biomedica Ltd., Xenios AG, MC3 Cardiopulmonary Inc., Lung Biotechnology PBC, Breethe Inc., Levitronix LLC, Medos Medizintechnik AG, ALung Technologies Inc., McGowan Institute for Regenerative Medicine, Hemovent GmbH, Novalung GmbH, Haemair Ltd., MedArray Inc., Vivonics Inc., Extracorporeal Life Support (ECLS) Lab

North America was the largest region in the artificial lung market in 2024. The regions covered in the artificial lung market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial lung market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The artificial lung market consists of sales of extracorporeal membrane oxygenation (ECMO), intravenous membrane oxygenators (IVOX), bioartificial lungs, and microfluidic artificial lungs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Lung Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial lung market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial lung ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial lung market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Single Roller Pump Heart Lung Machines; Double Roller Pump Heart Lungs Machines; Bubble Artificial Lung; Membrane Artificial Lung
  • 2) By Application: Cardiac Surgery; Lung Transplant Operation; Acute Respiratory Failure Treatment; Other Applications
  • 3) By End-Users: Hospital; Emergency Center; Other End-users
  • Subsegments:
  • 1) By Single Roller Pump Heart Lung Machines: Portable Single Roller Pump Heart Lung Machines; Stationary Single Roller Pump Heart Lung Machines
  • 2) By Double Roller Pump Heart Lung Machines: Portable Double Roller Pump Heart Lung Machines; Stationary Double Roller Pump Heart Lung Machines
  • 3) By Bubble Artificial Lung: Disposable Bubble Artificial Lung; Reusable Bubble Artificial Lung
  • 4) By Membrane Artificial Lung: Oxygenator Membrane Artificial Lung; Carbon Dioxide Removal Membrane Artificial Lung
  • Companies Mentioned: Terumo Corporation; Getinge AB; Abiomed Inc.; MicroPort Scientific Corp.; Charles Stark Draper Laboratory Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Lung Market Characteristics

3. Artificial Lung Market Trends And Strategies

4. Artificial Lung Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Artificial Lung Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Artificial Lung PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Artificial Lung Market Growth Rate Analysis
  • 5.4. Global Artificial Lung Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Artificial Lung Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Artificial Lung Total Addressable Market (TAM)

6. Artificial Lung Market Segmentation

  • 6.1. Global Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single Roller Pump Heart Lung Machines
  • Double Roller Pump Heart Lungs Machines
  • Bubble Artificial Lung
  • Membrane Artificial Lung
  • 6.2. Global Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cardiac Surgery
  • Lung Transplant Operation
  • Acute Respiratory Failure Treatment
  • Other Applications
  • 6.3. Global Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Emergency Center
  • Other End-user
  • 6.4. Global Artificial Lung Market, Sub-Segmentation Of Single Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Portable Single Roller Pump Heart Lung Machines
  • Stationary Single Roller Pump Heart Lung Machines
  • 6.5. Global Artificial Lung Market, Sub-Segmentation Of Double Roller Pump Heart Lung Machines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Portable Double Roller Pump Heart Lung Machines
  • Stationary Double Roller Pump Heart Lung Machines
  • 6.6. Global Artificial Lung Market, Sub-Segmentation Of Bubble Artificial Lung, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Disposable Bubble Artificial Lung
  • Reusable Bubble Artificial Lung
  • 6.7. Global Artificial Lung Market, Sub-Segmentation Of Membrane Artificial Lung, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oxygenator Membrane Artificial Lung
  • Carbon Dioxide Removal Membrane Artificial Lung

7. Artificial Lung Market Regional And Country Analysis

  • 7.1. Global Artificial Lung Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Artificial Lung Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Lung Market

  • 8.1. Asia-Pacific Artificial Lung Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Lung Market

  • 9.1. China Artificial Lung Market Overview
  • 9.2. China Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Lung Market

  • 10.1. India Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Lung Market

  • 11.1. Japan Artificial Lung Market Overview
  • 11.2. Japan Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Lung Market

  • 12.1. Australia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Lung Market

  • 13.1. Indonesia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Lung Market

  • 14.1. South Korea Artificial Lung Market Overview
  • 14.2. South Korea Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Lung Market

  • 15.1. Western Europe Artificial Lung Market Overview
  • 15.2. Western Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Lung Market

  • 16.1. UK Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Lung Market

  • 17.1. Germany Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Lung Market

  • 18.1. France Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Lung Market

  • 19.1. Italy Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Lung Market

  • 20.1. Spain Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Lung Market

  • 21.1. Eastern Europe Artificial Lung Market Overview
  • 21.2. Eastern Europe Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Lung Market

  • 22.1. Russia Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Lung Market

  • 23.1. North America Artificial Lung Market Overview
  • 23.2. North America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Lung Market

  • 24.1. USA Artificial Lung Market Overview
  • 24.2. USA Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Lung Market

  • 25.1. Canada Artificial Lung Market Overview
  • 25.2. Canada Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Lung Market

  • 26.1. South America Artificial Lung Market Overview
  • 26.2. South America Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Lung Market

  • 27.1. Brazil Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Lung Market

  • 28.1. Middle East Artificial Lung Market Overview
  • 28.2. Middle East Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Lung Market

  • 29.1. Africa Artificial Lung Market Overview
  • 29.2. Africa Artificial Lung Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Artificial Lung Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Artificial Lung Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Lung Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Lung Market Competitive Landscape
  • 30.2. Artificial Lung Market Company Profiles
    • 30.2.1. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Getinge AB Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. MicroPort Scientific Corp. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Charles Stark Draper Laboratory Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Lung Market Other Major And Innovative Companies

  • 31.1. TransMedics Group Inc.
  • 31.2. Braile Biomedica Ltd.
  • 31.3. Xenios AG
  • 31.4. MC3 Cardiopulmonary Inc.
  • 31.5. Lung Biotechnology PBC
  • 31.6. Breethe Inc.
  • 31.7. Levitronix LLC
  • 31.8. Medos Medizintechnik AG
  • 31.9. ALung Technologies Inc.
  • 31.10. McGowan Institute for Regenerative Medicine
  • 31.11. Hemovent GmbH
  • 31.12. Novalung GmbH
  • 31.13. Haemair Ltd.
  • 31.14. MedArray Inc.
  • 31.15. Vivonics Inc.

32. Global Artificial Lung Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Lung Market

34. Recent Developments In The Artificial Lung Market

35. Artificial Lung Market High Potential Countries, Segments and Strategies

  • 35.1 Artificial Lung Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Artificial Lung Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Artificial Lung Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer